Diabest Botanical Drugs has developed a dietary supplement to support blood glucose levels, based on Sarcopoterium spinosum extract to treat metabolic diseases. The company's treatment integrates a proprietary botanical extract method and optimized growing protocol for S. spinosum to maintain healthy blood sugar levels and avoid diabetic complications. Diabest's R&D has found that S. spinosum root extract exerts a significant anti-diabetic effect in mice. Other R&D activities include plant harvesting and production of dry extract and capsulation, optimization of growing protocol, and the characterization of S. spinosum ecotypes to generate increased biological activity. While focused on type-2 diabetes, the technology could potentially treat a wide range of metabolic disorders.